Dr Reddy's Laboratories on Thursday said it has settled patent litigation with Indivior Inc and Aquestive Therapeutics on a medication used to treat opioid dependence or addiction
Indivior on Friday said the restrictions of the previous restraining order remain in place, preventing Dr. Reddy's from selling or importing its generic buprenorphine/naloxone
